CHU Bordeaux
Bordeaux, France
NCT Number: NCT06451484
The aim is to improve the diagnosis of chronic lower limb venous thrombosis before a lower limb venous recanalization procedure. Additionally, if the MRI scores are comparable to those of the CT, MRI would reduce radiation exposure and limit the need for foot vein punctures that accompany CT use.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Bordeaux, France
Endovascular management of post-thrombotic syndrome (PTS) has created new opportunities for patients and interventional radiologists. PTS is the most chronic complication of deep vein thrombosis (DVT), occurring in 20% to 40% of patients despite optimal anticoagulant therapy within the first 1 to 2 years after a lower limb DVT. PTS is characterized by various symptoms lasting more than 6 months after a DVT, including mild pain or swelling, venous claudication, heaviness/fatigue, chronic pain or cramps, venous ulcers, edema, skin discoloration, and venous ectasia. Severe PTS negatively impacts quality of life. Several clinical tools or scales, such as the Villalta scale and CIVIQ-20, are used to diagnose and define PTS. Endovascular treatment of symptomatic chronic iliofemoral vein occlusions has shown good technical and clinical efficacy, with significant clinical benefits and improvements in the Villalta and CIVIQ scores. Proper planning of the recanalization procedure is essential, using CT and MRI imaging to analyze the venous anatomy in the pelvis, abdomen, and lower limbs. The CT is the reference examination for chronic lower limb thrombosis, performed using the Baldt technique to opacify the deep venous network and detect endoluminal adhesions. However, there are risks such as failure to puncture the veins on the back of the foot, pain during puncture, and flow artifacts. MRI is less commonly used due to its availability and long examination times, but its results are promising. The literature on chronic lower limb thrombosis is limited, with no consensus on lesion descriptions, highlighting the need for a descriptive lesion score
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Grade of vein severity on phleboscanner (from A-normal to D-very severe)
Time frame: Baseline
Grade of vein severity on MRI(from A-normal to D-very severe)
Time frame: Baseline
Intra-class correlation coefficient
Time frame: Baseline
Intra-class correlation coefficient
Time frame: Baseline
Intra-class correlation coefficient
University Hospital, Bordeaux
Other
Multicenter Study to Evaluate a Severity Score Using Venous MRI and CT in Patients With Post-Phlebitic Syndrome
Acronym: MR/CT PPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03195777
Cardiovascular Diseases, Deep Venous Thrombosis
Boston, Massachusetts, United States
View Trial DetailsNCT00687882
Cardiovascular Diseases, Embolism and Thrombosis
Birmingham, Alabama, United States
View Trial DetailsNCT05794932
Cardiovascular Diseases, Claudication, Intermittent
Montpellier, France
View Trial DetailsNCT02148029
Acute Deep Vein Thrombosis, Cardiovascular Diseases
Baltimore, Maryland, United States
View Trial Details